Maldives legalises ADHD medication methylphenidate
President Mohamed Muizzu ratified the amendments on Tuesday through a presidential decree.
Top Stories
-
Court authorises council to remove vessels from Vilimalé
-
FDC imposes fines in 23 cases involving regulation violations
-
Digital cards replace printed thalassaemia results in Maldives
-
MVR 19B on land reclamation, much of it unused: Auditor General
-
Around 90 single parents register for govt allowance each month
The Maldives has enacted legal amendments permitting the import and distribution of Methylphenidate for the treatment of Attention Deficit Hyperactivity Disorder.
The People's Majlis approved the changes on Monday, allowing the medication to be used in the country after previously being prohibited under the Drugs Act.
President Mohamed Muizzu ratified the amendments on Tuesday through a presidential decree.
According to the President's Office, the decision followed Cabinet discussions based on recommendations submitted by the National Drug Control Council.
The President’s Office stated that Parliament approved the removal of methylphenidate from the list of prohibited narcotics and added it to the schedule of controlled substances permitted for medical use.
The issue was recently raised with the President through a formal letter submitted by Mohamed Ibrahim regarding the need to make the medication available for ADHD patients in the Maldives.
The Maldives Food and Drug Authority had also requested parliamentary approval last year to authorise the import of the medication.
